Cynosure (CYNO) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cynosure Announces Fourth-Quarter 2015 Results; Achieves Record Quarterly Revenue of $102.4 Million, 19 Percent Increase from Prior Year
February 9, 2016 8:02 AM ESTWESTFORD, Mass., Feb. 9, 2016 /PRNewswire/ --Â Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months and year ended December 31, 2015.
"We capped a record year with fourth-quarter revenue of $102.4 million, improving margins and solid profitability in the quarter," said Chief Executive Officer Michael Davin. "The successful launch of SculpSure, our new laser platform for non-invasive fat reduction, together with the strong... More
